PerkinElmer Announces Global R&D Expansion in Singapore
News Mar 26, 2008
PerkinElmer, Inc. has celebrated the opening of a new Center of Excellence in Singapore. The PerkinElmer Inc. Center of Excellence in Singapore comes as part of PerkinElmer's continued global R&D expansion efforts, and will focus on the development of new instrumentation and chemistries for a range of scientific and industrial laboratory applications, including drug discovery and development, environmental monitoring, food safety, and sustainable energy.
The opening of the Center of Excellence was marked earlier by a celebration attended by employees, customers, partners and special guests. PerkinElmer global- and Singapore-based executives joined attendees at the new facility for the event, which included facility tours and a reception.
"We are pleased to establish the PerkinElmer Inc. Center of Excellence in Singapore as a base for our global R&D efforts," said Dr. Daniel R. Marshak, vice president and chief scientific officer, PerkinElmer, Inc.
"PerkinElmer is committed to growing its business globally and is making significant and long-term investments in Asia-Pacific to support the expansion of the health and environmental infrastructures of emerging growth nations. This investment in Singapore will enable us to leverage in-country expertise and resources to drive the development of new, innovative solutions to meet the changing needs of our global customers."
The new Center of Excellence will manufacture instruments for atomic absorption spectroscopy and UV/Visable spectroscopy to detect both inorganic and organic materials in the environment, food, materials and oil industries. The new facility will also focus R&D efforts in support of the expansion of PerkinElmer's EcoAnalytix™ solutions family.
EcoAnalytix is PerkinElmer's revolutionary problem-solving initiative that addresses the global imperatives of food and consumer product safety, water quality and sustainable energy development.
"PerkinElmer is committed to delivering world-class analytical measurement systems to help research and testing laboratories across the globe drive productivity, accuracy and quality," said Dr. Richard F. Begley, president, Analytical Sciences, PerkinElmer, Inc.
"The products that will be researched and developed here in Singapore will impact many aspects of our lives, from systems to test the safety of the water we drink and the quality of the air we breathe, to technology that may help to identify a new medication to cure a disease," Dr. Begley added.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019